Stay updated on Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.

Latest updates to the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA site-wide NIH notice about transitioning terminology from “Artificial Intelligence” to “Super Intelligence” appears, and the footer revision advances from v3.7.1 to v3.7.2. The study record remains inaccessible behind a 403 error.SummaryDifference1%

- Check18 days agoChange DetectedThe displayed site revision in the footer advances from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check39 days agoChange DetectedThe page now displays a 403 Forbidden error, preventing access to the study record and its associated documents. This change hides the study details that were previously visible on the page.SummaryDifference19%

- Check46 days agoChange DetectedThe page revision label was updated to v3.7.0, signaling an update to the page. The study content and displayed information remain unchanged.SummaryDifference0.1%

- Check60 days agoChange DetectedA new revision tag (Revision: v3.6.6) appears on the page, replacing the prior v3.6.5, indicating a background site update.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision: v3.6.5 was added and Revision: v3.6.4 was removed, representing a minor update to the page's revision label. This change reflects an internal update to the page template or documentation without altering study details or user-visible content.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- SBRT in Stage IV NSCLC Clinical Trial page.